AKT1 and metabolic dysfunction-associated steatotic liver disease: In the present study, our results revealed that PSPC effectively attenuated hepatocyte apoptosis by restoring the NAD+ depletion-mediated SirT1 loss, thereby suppressing p53-apoptotic pathway and enhancing Akt survival pathway, ultimately improving NAFLD.